Targeting STAT3 in gastric cancer

Bibliography

• Ferlay JSH, Bray F, Forman D, (2008) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer; 2010. 2008 ed
   Google Scholar
• Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60
   PubMed Web of Science ®Google Scholar
• Mora LB, Buettner R, Seigne J, Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002;62:6659-66
   PubMed Web of Science ®Google Scholar
• Song JI, Grandis JR. STAT signaling in head and neck cancer. Oncogene 2000;19:2489-95
   PubMed Web of Science ®Google Scholar
• Burke WM, Jin X, Lin HJ, Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001;20:7925-34
   PubMed Web of Science ®Google Scholar
• Corvinus FM, Orth C, Moriggl R, Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 2005;7:545-55
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Wrzeszczynska MH, Devgan G, Stat3 as an oncogene. Cell 1999;98:295-303
   PubMed Web of Science ®Google Scholar
• Willson TA, Kuhn BR, Jurickova I, STAT3 Genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric crohn disease. J Pediatr Gastroenterol Nutr 2011;55:32-43
   Google Scholar
• Rho O, Kim DJ, Kiguchi K, Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 2011;50:264-79
   Google Scholar
• Economescu MC, Necula LG, Dragu D, Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. Hepatogastroenterology 2010;57:1453-64
   Google Scholar
• Ellmark P, Ingvarsson J, Carlsson A, Identification of protein expression signatures associated with helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 2006;5:1638-46
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Ohno T, Graham DY, Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in mongolian gerbils. J Gastroenterol Hepatol 2011;26:77-84
   Google Scholar
• Nakayama T, Yoshizaki A, Izumida S, Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 2007;30:825-33
   PubMed Web of Science ®Google Scholar
• Howlett M, Giraud AS, Lescesen H, The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. Gastroenterology 2009;136:967-77
   PubMed Web of Science ®Google Scholar
• Ernst M, Najdovska M, Grail D, STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118:1727-38
   PubMed Web of Science ®Google Scholar
• Kanda N, Seno H, Konda Y, STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004;23:4921-9
   PubMed Web of Science ®Google Scholar
• Jackson CB, Judd LM, Menheniott TR, Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 2007;213:140-51
   PubMed Web of Science ®Google Scholar
• Testino G. Helicobacter pylori, cell proliferation, and carcinogenesis. Am J Gastroenterol 2001;96:2514
   Google Scholar
• Mandell L, Moran AP, Cocchiarella A, Intact gram-negative helicobacter pylori, helicobacter felis, and helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 2004;72:6446-54
   PubMedGoogle Scholar
• Correa P, Houghton J. Carcinogenesis of helicobacter pylori. Gastroenterology 2007;133:659-72
   PubMed Web of Science ®Google Scholar
• Court M, Robinson PA, Dixon MF, The effect of gender on helicobacter felis-mediated gastritis, epithelial cell proliferation, and apoptosis in the mouse model. J Pathol 2003;201:303-11
   Google Scholar
• Takaishi S, Cui G, Frederick DM, Synergistic inhibitory effects of gastrin and histamine receptor antagonists on helicobacter-induced gastric cancer. Gastroenterology 2005;128:1965-83
   PubMed Web of Science ®Google Scholar
• Lee CG, Hartl D, Matsuura H, Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am J Respir Cell Mol Biol 2008;39:739-46
   PubMed Web of Science ®Google Scholar
• Takaishi S, Tu S, Dubeykovskaya ZA, Gastrin is an essential cofactor for helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice. Am J Pathol 2009;175:365-75
   Google Scholar
• Judd LM, Alderman BM, Howlett M, Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004;126:196-207
   PubMed Web of Science ®Google Scholar
• Howlett M, Judd LM, Jenkins B, Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Gastroenterology 2005;129:1005-18
   Google Scholar
• Judd LM, Bredin K, Kalantzis A, STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 2006;131:1073-85
   PubMed Web of Science ®Google Scholar
• Howlett M, Menheniott TR, Judd LM, Cytokine signalling via gp130 in gastric cancer. Biochim Biophys Acta 2009;1793:1623-33
   PubMed Web of Science ®Google Scholar
• Tu S, Bhagat G, Cui G, Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008;14:408-19
   PubMed Web of Science ®Google Scholar
• Oshima H, Oshima M, Inaba K, Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004;23:1669-78
   PubMed Web of Science ®Google Scholar
• Oshima H, Matsunaga A, Fujimura T, Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006;131:1086-95
   PubMed Web of Science ®Google Scholar
• Itadani H, Oshima H, Oshima M, Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009;10:615
   Google Scholar
• Tomita H, Takaishi S, Menheniott TR, Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology 2011;140:879-91
   PubMed Web of Science ®Google Scholar
• Fox JG, Wang TC, Rogers AB, Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003;124:1879-90
   PubMedGoogle Scholar
• Spicer Z, Miller ML, Andringa A, Stomachs of mice lacking the gastric H,K-ATPase alpha -subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J Biol Chem 2000;275:21555-65
   Google Scholar
• Judd LM, Andringa A, Rubio CA, Gastric achlorhydria in H/K-ATPase-deficient (Atp4a(-/-)) mice causes severe hyperplasia, mucocystic metaplasia and upregulation of growth factors. J Gastroenterol Hepatol 2005;20:1266-78
   PubMed Web of Science ®Google Scholar
• Franic TV, van Driel IR, Gleeson PA, Reciprocal changes in trefoil 1 and 2 expression in stomachs of mice with gastric unit hypertrophy and inflammation. J Pathol 2005;207:43-52
   Google Scholar
• Xu J, Song P, Miller ML, Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach. Proc Natl Acad Sci USA 2008;105:17955-60
   PubMed Web of Science ®Google Scholar
• Song P, Groos S, Riederer B, KCNQ1 is the luminal K+ recycling channel during stimulation of gastric acid secretion. J Physiol 2009;587:3955-65
   Google Scholar
• Sandhiya S, Dkhar SA. Potassium channels in health, disease & development of channel modulators. Indian J Med Res 2009;129:223-32
   PubMedGoogle Scholar
• Recalde S, Muruzabal F, Looije N, Inefficient chronic activation of parietal cells in Ae2a,b(-/-) mice. Am J Pathol 2006;169:165-76
   Google Scholar
• Heitzmann D, Warth R. No potassium, no acid: K+ channels and gastric acid secretion. Physiology (Bethesda) 2007;22:335-41
   Google Scholar
• Lefebvre O, Chenard MP, Masson R, Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62
   PubMed Web of Science ®Google Scholar
• Zavros Y, Eaton KA, Kang W, Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 2005;24:2354-66
   Google Scholar
• Tebbutt NC, Giraud AS, Inglese M, Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002;8:1089-97
   PubMed Web of Science ®Google Scholar
• Jenkins BJ, Grail D, Nheu T, Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 2005;11:845-52
   PubMed Web of Science ®Google Scholar
• Franic TV, Judd LM, Robinson D, Regulation of gastric epithelial cell development revealed in H(+)/K(+)-ATPase beta-subunit- and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol 2001;281:G1502-11
   Web of Science ®Google Scholar
• Howlett M, Chalinor HV, Buzzelli JN, IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut 2012; In press
   Google Scholar
• Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007;13:5547-51
   PubMed Web of Science ®Google Scholar
• Kabir S. The role of interleukin-17 in the helicobacter pylori induced infection and immunity. Helicobacter 2011;16:1-8
   Google Scholar
• Gaffen SL. Biology of recently discovered cytokines: interleukin-17–a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther 2004;6:240-7
   PubMed Web of Science ®Google Scholar
• Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010;10:248-56
   PubMed Web of Science ®Google Scholar
• Jarnicki A, Putoczki T, Ernst M. Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? Cell Div 2010;5:14
   PubMed Web of Science ®Google Scholar
• Nishihara M, Ogura H, Ueda N, IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 2007;19:695-702
   PubMed Web of Science ®Google Scholar
• Caruso R, Fina D, Paoluzi OA, IL-23-mediated regulation of IL-17 production in helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008;38:470-8
   PubMed Web of Science ®Google Scholar
• Mitchell P, Germain C, Fiori PL, Chronic exposure to helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun 2007;75:810-19
   PubMed Web of Science ®Google Scholar
• Khamri W, Walker MM, Clark P, Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 2010;78:845-53
   PubMed Web of Science ®Google Scholar
• Flach CF, Ostberg AK, Nilsson AT, Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect Immun 2011;79:879-86
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Oncogenic mechanisms of the helicobacter pylori CagA protein. Nat Rev Cancer 2004;4:688-94
   PubMed Web of Science ®Google Scholar
• Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005;96:835-43
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. SagA of CagA in helicobacter pylori pathogenesis. Curr Opin Microbiol 2008;11:30-7
   PubMedGoogle Scholar
• Kuipers EJ, Perez-Perez GI, Meuwissen SG, Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80
   PubMed Web of Science ®Google Scholar
• Ohnishi N, Yuasa H, Tanaka S, Transgenic expression of helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008;105:1003-8
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhong X, Zheng S, Transformed immortalized gastric epithelial cells by virulence factor CagA of helicobacter pylori through Erk mitogen-activated protein kinase pathway. Oncogene 2005;24:3886-95
   Google Scholar
• Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000;97:1263-8
   PubMed Web of Science ®Google Scholar
• Tsutsumi R, Higashi H, Higuchi M, Attenuation of helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003;278:3664-70
   PubMed Web of Science ®Google Scholar
• Poppe M, Feller SM, Romer G, Phosphorylation of helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 2007;26:3462-72
   Google Scholar
• Higashi H, Tsutsumi R, Muto S, SHP-2 tyrosine phosphatase as an intracellular target of helicobacter pylori CagA protein. Science 2002;295:683-6
   PubMed Web of Science ®Google Scholar
• Mimuro H, Suzuki T, Tanaka J, Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 2002;10:745-55
   PubMedGoogle Scholar
• Churin Y, Al-Ghoul L, Kepp O, Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003;161:249-55
   PubMed Web of Science ®Google Scholar
• Saadat I, Higashi H, Obuse C, Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007;447:330-3
   PubMed Web of Science ®Google Scholar
• Murata-Kamiya N, Kurashima Y, Teishikata Y, Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007;26:4617-26
   PubMed Web of Science ®Google Scholar
• Lee KS, Kalantzis A, Jackson CB, Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3gamma via gastric STAT3 activation. PLoS One 2012;7:e30786
   PubMed Web of Science ®Google Scholar
• Higashi H, Nakaya A, Tsutsumi R, Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004;279:17205-16
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mimuro H, Suzuki T, Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 2005;202:1235-47
   PubMed Web of Science ®Google Scholar
• Bronte-Tinkew DM, Terebiznik M, Franco A, Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 2009;69:632-9
   PubMed Web of Science ®Google Scholar
• Lee IO, Kim JH, Choi YJ, Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem 2010;285:16042-50
   PubMed Web of Science ®Google Scholar
• Higashi H, Yokoyama K, Fujii Y, EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 2005;280:23130-7
   Google Scholar
• Matsumoto A, Isomoto H, Nakayama M, Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells. Dig Dis Sci 2011;56:999-1006
   PubMed Web of Science ®Google Scholar
• Kim B, Bang S, Lee S, Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 2003;63:8248-55
   PubMedGoogle Scholar
• Sneddon JB, Zhen HH, Montgomery K, Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA 2006;103:14842-7
   PubMed Web of Science ®Google Scholar
• Namkoong H, Shin SM, Kim HK, The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 2006;6:74
   Google Scholar
• Gallagher PG, Bao Y, Prorock A, Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res 2005;65:4134-46
   PubMed Web of Science ®Google Scholar
• Han JC, Zhang KL, Chen XY, Expression of seven gastric cancer-associated genes and its relevance for Wnt, NF-kappaB and Stat3 signaling. APMIS 2007;115:1331-43
   Google Scholar
• Deng JY, Sun D, Liu XY, STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol 2010;16:5380-7
   PubMed Web of Science ®Google Scholar
• Deng J, Grande F, Neamati N. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007;7:91-107
   PubMed Web of Science ®Google Scholar
• Yue P, Turkson J. Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs 2009;18:45-56
   PubMed Web of Science ®Google Scholar
• Mankan AK, Greten FR. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors. Expert Opin Investig Drugs 2011;20:1263-75
   PubMed Web of Science ®Google Scholar
• Page BD, Fletcher S, Yue P, Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain. Bioorg Med Chem Lett 2011;21:5605-9
   PubMed Web of Science ®Google Scholar
• Trepicchio WL, Dorner AJ. The therapeutic utility of Interleukin-11 in the treatment of inflammatory disease. Expert Opin Investig Drugs 1998;7:1501-4
   PubMedGoogle Scholar
• Hayashi M, Rho MC, Enomoto A, Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130. Proc Natl Acad Sci USA 2002;99:14728-33
   Google Scholar
• Underhill-Day N, McGovern LA, Karpovich N, Functional characterization of W147A: a high-affinity interleukin-11 antagonist. Endocrinology 2003;144:3406-14
   Google Scholar
• Dimitriadis E, Menkhorst E. New generation contraceptives: interleukin 11 family cytokines as non-steroidal contraceptive targets. J Reprod Immunol 2011;88:233-9
   PubMed Web of Science ®Google Scholar
• Nelson EA, Sharma SV, Settleman J, A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation. Oncotarget 2011;2:518-24
   PubMed Web of Science ®Google Scholar
• Park E, Park J, Han SW, NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations. Int J Oncol 2012;40:1259-66
   PubMed Web of Science ®Google Scholar
• Iwamaru A, Szymanski S, Iwado E, A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 2006;26:2435-2444
   Google Scholar
• Gong W, Wang L, Yao JC, Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res 2005;11:1386-93
   PubMed Web of Science ®Google Scholar
• Kim DY, Cha ST, Ahn DH, STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol 2009;24:646-51
   PubMed Web of Science ®Google Scholar
• Yakata Y, Nakayama T, Yoshizaki A, Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol 2007;30:437-42
   PubMed Web of Science ®Google Scholar
• Lee J, Kang WK, Park JO, Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS 2009;117:598-606
   PubMed Web of Science ®Google Scholar
• Cheong JH, Hong SY, Zheng Y, Eupatilin inhibits gastric cancer cell growth by blocking STAT3-mediated VEGF expression. J Gastric Cancer 2011;11:16-22
   PubMedGoogle Scholar
• Chen J, Wang J, Lin L, Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther 2012;11:277-87
   PubMed Web of Science ®Google Scholar
• Uehara Y, Mochizuki M, Matsuno K, Novel high-throughput screening system for identifying STAT3-SH2 antagonists. Biochem Biophys Res Commun 2009;380:627-31
   PubMed Web of Science ®Google Scholar
• Huang S, Chen M, Shen Y, Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. Cancer Lett 2012;315:198-205
   PubMed Web of Science ®Google Scholar
• Zhu BH, Chen HY, Zhan WH, (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol 2011;17:2315-25
   PubMed Web of Science ®Google Scholar
• Bang YJ, Van Cutsem E, Feyereislova A, Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687-97
   PubMed Web of Science ®Google Scholar
• Deng N, Goh LK, Wang H, A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 2012;61:673-84
   PubMed Web of Science ®Google Scholar
• Tai WT, Cheng AL, Shiau CW, Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3. Mol Cancer Ther 2012;11:452-63
   Google Scholar
• Lim CP, Fu XY. Multiple roles of STAT3 in cardiovascular inflammatory responses. Prog Mol Biol Transl Sci 2012;106:63-73
   PubMed Web of Science ®Google Scholar
• Haghikia A, Stapel B, Hoch M, STAT3 and cardiac remodeling. Heart Fail Rev 2011;16:35-47
   PubMed Web of Science ®Google Scholar
• Obana M, Maeda M, Takeda K, Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation 2010;121:684-91
   PubMed Web of Science ®Google Scholar
• Manukyan MC, Alvernaz CH, Poynter JA, Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway. Surgery 2011;150:231-9
   Google Scholar
• Wegrzyn J, Potla R, Chwae YJ, Function of mitochondrial Stat3 in cellular respiration. Science 2009;323:793-7
   PubMed Web of Science ®Google Scholar
• Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 2006;6:379-86
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler J, Rennick D, Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74
   PubMed Web of Science ®Google Scholar
• Glocker EO, Kotlarz D, Boztug K, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033-45
   PubMed Web of Science ®Google Scholar